Analysis of chromosomes 3, 7, X and the EGFR gene in uterine cervical cancer progression

European Journal of Cancer

Volumn 40, Issue 10, 2004, Pages 1624-1629

  Marzano, R ^a   Corrado, G ^a   Merola, R ^a   Sbiroli, C ^a   Guadagni, F ^a   Vizza, E ^a   Del Nonno, F ^a   Carosi, M ^a   Galati M, M ^a   Sperduti, I ^a   Cianciulli, A M ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Cervical carcinoma; Genetic markers; Progression

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CENTROMERE; CHROMOSOME 3; CHROMOSOME 7; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; KRUSKAL WALLIS TEST; PRIORITY JOURNAL; RISK; STATISTICAL SIGNIFICANCE; UTERINE CERVIX CANCER; X CHROMOSOME;

ADULT; AGED; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 7; CHROMOSOMES, HUMAN, X; DISEASE PROGRESSION; FEMALE; GENETIC MARKERS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; RECEPTOR, EPIDERMAL GROWTH FACTOR; UTERINE CERVICAL NEOPLASMS;

EID: 2942514601     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2004.03.015     Document Type: Article

References (17)

1. Crum C., McLachlin C.M. Cervical intraepithelial neoplasia. J. Cell Biochem. Suppl. 23:1995;71-79
2. Morris M., Tortolero-Luna G., Malpica A., et al. Cervical intraepithelial neoplasia and cervical cancer. Obstet. Gynecol. Clin. North Am. 23:1996;347-410
3. Rubin S.C., Hoskins W.J. Cervical cancer and preinvasive neoplasia. 1996;Lippincott-Raven, New York
4. Lazo P. The molecular genetics of cervical carcinoma. Br. J. Cancer. 80:1999;2008-2018
5. Mian C., Bancher D., Kohlberger P., et al. Fluorescence in situ hybridization in cervical smears: detection of numerical aberrations of chromosomes 7, 3, X and relationship to HPV infection. Gynecol. Oncol. 75:1999;41-46
6. Kirchoff M., Rose H., Petersen B.L., et al. Comparative genomic hybridization reveals non-random chromosomal aberrations in early preinvasive cervical lesions. Cancer Genet. Cytogenet. 129:2001;47-51
7. Dam V.P.A., Lowe D.G., Watson J.V., et al. Multiparameter flow-cytometric quantitation of epidermal growth factor receptor and c-erB-2 oncoprotein in normal and neoplastic tissues of the female genital tract. Gynecol. Oncol. 42:1991;256-264
8. Ostor A.G. Natural history of cervical intraepithelial neoplasia: a critical review. Int. J. Gynecol. Pathol. 12:1993;186-192
9. Solomon D., Davey D., Kurman R., et al. The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA. 287:2002;2114-2119
10. Castle P.E., Wacholder S., Lorincz A.T., et al. A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. J. Natl. Cancer Inst. 94:2002;1406-1414
11. Kersemaekers A.M., Fleuren G.J., Kenter G.G., et al. Oncogene alterations in carcinomas of the uterine cervix: overexpression of epidermal growth factor receptor is associated with poor prognosis. Clin. Cancer Res. 5:1999;577-586
12. Kurtycz D., Nunez M., Arts T., et al. Use of fluorescent in situ hybridization to detect aneuploidy in cervical dysplasia. Diagn. Cytopathol. 15:1996;46-51
13. Heselmeyer-Haddad K., Janz V., Castle P.E., et al. Detection of genomic amplification of the Human Telomerase Gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia. Am. J. Pathol. 163:2003;1405-1416
14. Heselmeyer K., Macville M., Schrock E., et al. Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q. Genes Chromosomes Canc. 19:1997;233-240
15. Bulten J., Poddighe P.J., Robben J.C., et al. Interphase cytogenetics analysis of cervical intraepithelial neoplasia. Am. J. Pathol. 152:1998;495-503
16. Gaffney D.K., Haslam D.B.A., Tsodikov A., et al. Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy. Int. J. Radiat. Oncol. 56:2003;922-928
17. Crusius K., Auvinen E., Alonso A. Enhancement of EGF- and MAP-mediated MAP kinase activation in cells expressing the human papillomavirus type 16 E5 protein. Oncogene. 15:1997;1437-1444